Combined all‐trans retinoic acid with low‐dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: A single‐center, secondary analysis of a phase II study

BACKGROUND: Treatment options are limited for recurrent/metastatic adenoid cystic carcinoma of the head and neck (R/M ACCHN). We aimed to evaluate the preliminary results of the efficacy and safety of all‐trans retinoic acid (ATRA) combined with low‐dose apatinib in patients with R/M ACCHN according...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lulu, Zhang, Lin, Li, Rongrong, Pan, Xinhua, Li, Jiang, Dou, Shengjin, Jiang, Wen, Wang, Chong, Chen, Wantao, Zhu, Guopei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166967/
https://www.ncbi.nlm.nih.gov/pubmed/36734294
http://dx.doi.org/10.1002/cam4.5653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166967/
https://www.ncbi.nlm.nih.gov/pubmed/36734294
http://dx.doi.org/10.1002/cam4.5653

Ejemplares similares